Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

See our updated masking policy »

Stanford Health Care

Blood and marrow transplant clinical trials network state of the science symposium 2007 BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION Ferrara, J. L., Anasetti, C., Stadtmauer, E., Antin, J., Wingard, J., Lee, S., Levine, J., Schultz, K., Appelbaum, F., Negrin, R., Giralt, S., Bredeson, C., Heslop, H., Horowitz, M. 2007; 13 (11): 1268-1285

Abstract

Outcomes of hematopoietic cell transplantation are steadily improving. New techniques have reduced transplant toxicities, and there are new sources of hematopoietic stem cells from unrelated donors. In June 2007 the Blood and Marrow Transplant Clinical Trials Network convened a State of the Science Symposium of more than 200 participants in Ann Arbor to identify the most compelling clinical research opportunities in the field. This report summarizes the symposium's discussions and identifies eleven high priority clinical trials that the network plans to pursue over the course of the next several years.

View details for DOI 10.1016/j.bbmt.2007.08.005

View details for Web of Science ID 000250813000002

View details for PubMedID 17950914